San Antonio Marriott Rivercenter, Salon E

These CME symposia are sponsored by Clinical Care Options, LLC. “Experts Debate and Discuss Therapeutic Strategies Using CDK4/6 Inhibitors Across Breast Cancer” is supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation. “Estrogen Receptor Mutations in HR+ Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions” is supported by educational grants from AstraZeneca and Lilly.